Beryl Drugs Ltd — Results, 30-05-2025: Result

Beryl Drugs has announced a board meeting to consider the financial results for the quarter and half-year. The company reported total revenue of Rs. 521.96 lakhs for the quarter and Rs. 2,255.48 lakhs for the year, with a net profit of Rs. 15.19 lakhs and Rs. 57.89 lakhs respectively. Production was temporarily halted in the FFS section for WHO-GMP compliance upgrades, resulting in lower turnover; WHO-GMP certification was obtained recently. The company wrote off Rs. 23.75 lakhs in bad trade receivables and reversed certain prior period statutory liabilities totaling Rs. 5.28 lakhs. Kotak Mahindra Bank loan balance is now nil. The auditors issued an unmodified opinion on the results.